220 related articles for article (PubMed ID: 31493443)
1. Cancer stem cells in prostate cancer radioresistance.
Tsao T; Beretov J; Ni J; Bai X; Bucci J; Graham P; Li Y
Cancer Lett; 2019 Nov; 465():94-104. PubMed ID: 31493443
[TBL] [Abstract][Full Text] [Related]
2. Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.
Chang L; Graham PH; Hao J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
Cancer Metastasis Rev; 2014 Sep; 33(2-3):469-96. PubMed ID: 24445654
[TBL] [Abstract][Full Text] [Related]
3. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
[TBL] [Abstract][Full Text] [Related]
4. SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties.
Yadav S; Kowolik CM; Lin M; Zuro D; Hui SK; Riggs AD; Horne DA
Mol Carcinog; 2019 Jan; 58(1):113-125. PubMed ID: 30242889
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia.
Marie-Egyptienne DT; Lohse I; Hill RP
Cancer Lett; 2013 Nov; 341(1):63-72. PubMed ID: 23200673
[TBL] [Abstract][Full Text] [Related]
6. Low production of reactive oxygen species and high DNA repair: mechanism of radioresistance of prostate cancer stem cells.
Kim YS; Kang MJ; Cho YM
Anticancer Res; 2013 Oct; 33(10):4469-74. PubMed ID: 24123017
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells.
Cojoc M; Peitzsch C; Kurth I; Trautmann F; Kunz-Schughart LA; Telegeev GD; Stakhovsky EA; Walker JR; Simin K; Lyle S; Fuessel S; Erdmann K; Wirth MP; Krause M; Baumann M; Dubrovska A
Cancer Res; 2015 Apr; 75(7):1482-94. PubMed ID: 25670168
[TBL] [Abstract][Full Text] [Related]
8. The Role of Canonical Wnt Signaling in Regulating Radioresistance.
Zhao Y; Tao L; Yi J; Song H; Chen L
Cell Physiol Biochem; 2018; 48(2):419-432. PubMed ID: 30021193
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer: radioresistance molecular target-related markers and foreseeable modalities of radiosensitization.
Alberti C
Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2275-82. PubMed ID: 25219826
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of epithelial-mesenchymal-transition (EMT) signature and PARP-1 in prostate cancer radioresistance.
Stark TW; Hensley PJ; Spear A; Pu H; Strup SS; Kyprianou N
Prostate; 2017 Dec; 77(16):1583-1591. PubMed ID: 29063620
[TBL] [Abstract][Full Text] [Related]
11. Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.
Mandal S; Arfuso F; Sethi G; Dharmarajan A; Warrier S
Int J Biochem Cell Biol; 2019 May; 110():59-69. PubMed ID: 30735730
[TBL] [Abstract][Full Text] [Related]
12. Reactive Oxygen Species-Mediated Tumor Microenvironment Transformation: The Mechanism of Radioresistant Gastric Cancer.
Gu H; Huang T; Shen Y; Liu Y; Zhou F; Jin Y; Sattar H; Wei Y
Oxid Med Cell Longev; 2018; 2018():5801209. PubMed ID: 29770167
[TBL] [Abstract][Full Text] [Related]
13. Targeting MicroRNAs in Prostate Cancer Radiotherapy.
Ni J; Bucci J; Chang L; Malouf D; Graham P; Li Y
Theranostics; 2017; 7(13):3243-3259. PubMed ID: 28900507
[TBL] [Abstract][Full Text] [Related]
14. Profiles of Radioresistance Mechanisms in Prostate Cancer.
Chaiswing L; Weiss HL; Jayswal RD; Clair DKS; Kyprianou N
Crit Rev Oncog; 2018; 23(1-2):39-67. PubMed ID: 29953367
[TBL] [Abstract][Full Text] [Related]
15. [Cancer stem cells: Radiotherapeutic features and therapeutic targets].
Méry B; Rancoule C; Guy JB; Espenel S; Wozny AS; Simonet S; Vallard A; Alphonse G; Ardail D; Rodriguez-Lafrasse C; Magné N
Bull Cancer; 2016 Jan; 103(1):48-54. PubMed ID: 26702506
[TBL] [Abstract][Full Text] [Related]
16. A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics.
Harner-Foreman N; Vadakekolathu J; Laversin SA; Mathieu MG; Reeder S; Pockley AG; Rees RC; Boocock DJ
Sci Rep; 2017 Jan; 7():40633. PubMed ID: 28094783
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression.
Rybak AP; Bristow RG; Kapoor A
Oncotarget; 2015 Feb; 6(4):1900-19. PubMed ID: 25595909
[TBL] [Abstract][Full Text] [Related]
18. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.
Olivares-Urbano MA; Griñán-Lisón C; Marchal JA; Núñez MI
Cells; 2020 Jul; 9(7):. PubMed ID: 32660072
[TBL] [Abstract][Full Text] [Related]
19. Radioresistant breast cancer cells exhibit increased resistance to chemotherapy and enhanced invasive properties due to cancer stem cells.
Ko YS; Jin H; Lee JS; Park SW; Chang KC; Kang KM; Jeong BK; Kim HJ
Oncol Rep; 2018 Dec; 40(6):3752-3762. PubMed ID: 30272295
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
